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Abstract
Background—The clinical and etiological relation between autism spectrum disorders (ASD)
and schizophrenia is unclear. The degree to which these disorders share a basis in etiology has
important implications for clinicians, researchers, and those affected. Our objective was to
determine if a family history of schizophrenia and/or bipolar disorder was a risk factor for ASD.
We conducted a case-control evaluation of histories of schizophrenia or bipolar disorder in first-
degree relatives of probands in three samples, population registers in Sweden, Stockholm County,
and Israel. Probands met criteria for ASD, and affection status of parents and siblings for
schizophrenia and bipolar disorder were established.
Findings—The presence of schizophrenia in parents was associated with an increased risk for
ASD in a Swedish national cohort (odds ratio 2.9, 95% CI 2.5–3.4) and in a Stockholm County
cohort (odds ratio 2.9, 95% CI 2.0–4.1). Similarly, schizophrenia in a sibling was associated with
an increased risk for ASD in a Swedish national cohort (odds ratio 2.6, 95% CI 2.0–3.2) and in an
Israeli conscription cohort (odds ratio 12.1, 95% CI 4.5–32). Bipolar disorder showed a similar
pattern of associations but of lesser magnitude.
Interpretation—Findings from these three registers along with consistent findings from a similar
study in Denmark suggest that ASD, schizophrenia, and bipolar disorder share common
etiological factors.
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INTRODUCTION
Autism spectrum disorders (ASD) and schizophrenia are currently considered as distinctive
and infrequently overlapping 1, 2. Historically, ASD was often regarded as childhood
schizophrenia as the impaired social interactions and bizarre behavior found in ASD were
reminiscent of symptoms of schizophrenia 3. Indeed, the psychiatrist who coined the term
schizophrenia counted “autism” (an active turning away from the external world) as an
important distinguishing feature of schizophrenia 4, 5. Around 1980, the nosological status of
ASD and schizophrenia was revised so that these disorders were separated 6. The separation
was strongly influenced by developmental trajectory, and delineated infantile autism present
from very early in life 7 from schizophrenia where psychotic symptoms developed after an
extended period of normal or near-normal development.
Several lines of evidence suggest that this distinction is not absolute, and that there are
important overlaps between ASD and schizophrenia. Some family history studies 8, 9
(although not all) 10 found that the relatives of probands with ASD were more likely to have
a history of schizophrenia. However, these studies tended to be small and relatively
underpowered. Childhood-onset schizophrenia is a rare subtype, and a sizable fraction have
premorbid ASD 11. More directly, genome-wide copy number variation studies have
identified rare mutations that are strong risk factors for both ASD and schizophrenia (e.g.,
15q13.3, 16p11.2, 22q11.21, and in neurexin 1) 12–15. These points of overlap are quite
uncommon, and apply to only a fraction of clinical samples.
The degree to which ASD and schizophrenia share etiological factors has important
implications for clinicians, researchers, and those affected by these diseases. Therefore, we
investigated if a family history of schizophrenia and/or bipolar disorder in first-degree
relatives was a risk factor for ASD. Bipolar disorder was included given its etiological and
clinical overlap with schizophrenia 16, 17. We conducted parallel analyses in three samples to
evaluate the consistency and generalizability of the findings.
MATERIALS AND METHODS
The overall goal of this study was to evaluate the impact of the “exposure” of family history
of schizophrenia and bipolar disorder (psychotic disorders) on the outcome of ASD. This
relation was evaluated in three complementary samples. Study 1 has Swedish national
coverage of inpatient and outpatient admissions. Study 2 is based on an inclusive set of
primarily outpatient ASD treatment facilities but limited to the largest population center in
Sweden (Stockholm County). Study 3 employs standardized psychiatric assessment of
conscripts in Israel. ASD outcomes were assessed using register data, and exposures
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measured using register data on parents (Studies 1 and 2) or siblings (Studies 1 and 3).
These studies were approved by research ethics committees at Karolinska Institutet and
Sheba Medical Center.
Study 1 (Sweden National Patient Register, NPR) was conducted using Swedish national
registers. An analysis of 27% of these cases was published previously 8. The primary key for
register linkage was the unique personal identification number assigned to each Swedish
citizen at birth or upon arrival in Sweden for immigrants 18. The NPR 19, 20 contains
discharge diagnoses for all inpatient (since 1973) and outpatient (since 2001) psychiatric
treatment in Sweden including admissions for assessment or treatment to any psychiatric or
general medical hospital (including forensic psychiatric hospitals and the few private
providers of inpatient healthcare). Biological relationships were established using the Multi-
Generation Register 21 which identifies the relatives of an index person through linkage of a
child to his or her parents, and includes all individuals born in Sweden since 1932, those
registered as living in Sweden after 1960, and immigrants who became Swedish citizens
before age 18. Vital status was defined using the national Cause of Death Register. Cases
were defined by the presence of a discharge diagnosis of an ASD (ICD-9 299 or ICD-10
F84). To avoid bias due to diagnostic uncertainty, 2,147 ASD cases who had ever received a
discharge diagnosis of schizophrenia (ICD-8 295.0–295.4, 295.6 or 295.8–295.9; ICD-9
295A-295E, 295G or 295W-295X; or ICD-10 F20) or bipolar disorder (ICD-8 296.1, 296.3,
296.8; ICD-9 296A, 296C-296E or 296W; or ICD-10: F30–F31) were excluded. Ten
control-relative pairs were randomly selected and matched to each case-relative pair.
Controls met the following criteria: same sex and year of birth as the index case; alive,
living in Sweden, and no ASD diagnosis up to the time of the proband’s initial diagnosis (to
avoid bias due to left truncation and to ensure equivalent follow-up times for relatives of
probands and controls) 22, 23; and controls who had ever received a discharge diagnosis of
schizophrenia or bipolar disorder were excluded to avoid bias due to diagnostic uncertainty.
Controls were also required to have a relative individually matched to the relative of a case
by biological relationship, sex, and year of birth. We estimated the relation between the
exposure (family history of schizophrenia or bipolar disorder) and the outcome (ASD) using
odds ratios (ORs) with 95% confidence intervals (CIs) from conditional logistic regression
models in PROC PHREG in SAS (v9.2) 24. We adjusted the CIs for non-independence
within family clusters using a robust sandwich estimator function (PHREG “covsandwich”
option).
Study 2 (Stockholm inpatient and outpatient) was also conducted using Swedish registries25.
The base for Study 2 was all youth aged 0–17 years registered in Stockholm County from
1984–2007 (N=589,114). Cases were drawn from health services registers from Stockholm
County and had: DSM-IV diagnosis of pervasive development disorder in the Stockholm
County Council Child and Adolescent Mental Health Service Register 26; treatment at the
Autism Centre for Young Children, Asperger Centre, or Autism Centre within Stockholm
County Council Handicap and Habilitation services; or NPR diagnosis of ASD (ICD-9 299
or ICD-10 F84). Given that mental retardation is a source of heterogeneity in ASD 27, cases
were also stratified by the presence or absence of clinically significant mental retardation
(i.e., treatment at clinical centers specifically for ASD comorbid with mental retardation, a
diagnosis of mental retardation in any register, or ASD subtype other than Asperger's
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syndrome). We randomly selected 10 control-relative pairs for each case. Controls also
resided in Stockholm County, had no evidence of ASD (i.e., no treatment or NPR
diagnosis), and were matched to cases by year of birth and sex as well as by the year of birth
of the father and mother. The main exposures were schizophrenia (ICD-8 295.0–295.9,
ICD-9 295A-295X, ICD-10 F20) or bipolar disorder (ICD-8 296.0–296.9, ICD-9
296A-296W, ICD-10 F31) in the parents of cases and controls. These exposures were
assessed using the NPR supplemented by psychiatric out-patient treatment registers
available in Stockholm county. The statistical analysis paralleled that used in Study 1.
Study 3 (Israeli conscripts). All Jewish persons born in Israel are required to participate in
an assessment at age 17 prior to compulsory military service. Participation rates are 98% for
males and 75% for females (women adhering to Orthodox Judaism are exempted) 28. The
pre-induction assessment determines intellectual, medical, and psychiatric eligibility for
compulsory military service. The draft board registry data were used to obtain the diagnostic
outcomes for ASD probands and their siblings at age 17 years. Psychiatric diagnostic
procedures are described elsewhere, and ICD-10 psychiatric diagnoses for ASD and
schizophrenia were assigned by a board-certified psychiatrist experienced in treating
adolescents 28, 29. Mood disorder diagnoses for bipolar and major depressive disorder could
not confidently be assigned. Draft board psychiatrists had access to additional information
for subjects under specialty care for developmental disorders. Eligible subjects were born
during ten consecutive years beginning in the 1980's. Sibships within the cohort were
identified using the parental national identification numbers, which are assigned to all
citizens at birth or upon immigration. There were 436,697 sibships with at least two siblings
per sibship, 386 ASD sibships where one sibling had a diagnosis of ASD, and 436,311
control sibships where no sibling had a diagnosis of ASD. For analysis, one non-ASD-
sibling was randomly selected from ASD sibships, and one sibling was randomly selected
from control sibships. As in Studies 1 and 2, the association between the exposure of sibling
diagnosis of schizophrenia with proband ASD was tested using logistic regression.
Quality of register diagnoses. Swedish register diagnoses have been subjected to extensive
scrutiny. The NPR is of high quality 19. For schizophrenia, the definition of affection has
passed peer review on multiple occasions, direct review of case notes yields very high
agreement 20, 30, the prevalence and recurrence risks to relatives 22 are nearly identical to
that accepted by the field 31–34, and, most importantly, genomic findings in Swedish
samples are highly consistent with those from conventionally phenotyped cases 16, 35, 36. For
ASD, NPR diagnoses have good validity 37, and we have shown high agreement via review
of case notes (96%). Similarly, for the Israeli register, validity has been established 28, 29.
RESULTS
We investigated the association of schizophrenia and bipolar disorder in first-degree
relatives (parents or siblings) with ASD using three samples. Descriptive data for the three
studies are given in Table 1. Study 1 used a Swedish national sampling frame with outcome
and exposure diagnoses defined using a national patient register. Study 2 provided
complementary data based on Stockholm County outpatient and inpatient health service
Sullivan et al. Page 4






















registers. Study 3 capitalized on a standardized national pre-conscription assessment in
Israel. Male sex predominated in all samples, consistent with a US survey (76–88%) 38.
Table 2 shows associations between family history exposures and ASD outcome for all three
studies. The exposure of schizophrenia in parents was a significant risk factor for ASD in
probands with odds ratios (ORs) of 2.9 in both Studies 1 and 2. Studies 1 and 2 had modest
overlap (~22% of the Swedish population live in the Stockholm County). Reanalysis of
Study 2 after removal of inpatient ASD cases also in Study 1 yielded consistent ORs.
Sibling data were available in Studies 1 and 3, and the exposure of schizophrenia in siblings
was also a significant risk factor for ASD (ORs of 2.6 and 12.1 in Studies 1 and 3). The
estimate from Study 3 was numerically larger, but the smaller sample size gave relatively
large confidence intervals. Notably, the ORs for parents and siblings in Study 1 were
numerically similar.
Studies 1 and 2 had data on the exposure of bipolar disorder in parents as a risk factor for
proband ASD. These associations were positive (ORs of 1.9 and 1.6 with overlapping
confidence intervals). Study 1 showed similar effects for the exposure of sibling bipolar
disorder.
Additional data available in Study 2 allowed stratification of ASD cases by the presence
(41.8%) or absence of mental retardation (58.2%). The exposure of family history of
schizophrenia or bipolar disorder with ASD was principally in cases without clinical
indication of mental retardation. For ASD cases without mental retardation, ORs were 2.6
for schizophrenia and 1.5 for bipolar disorder compared to 1.6 and 1.1 for ASD cases with
mental retardation.
Analyses evaluating the effect of sex did not reveal marked differences in associations
between the exposures and ASD in Studies 1–3 as the adjusted ORs were relatively
homogeneous with respect to the sex of the ASD case and the sex of the relative.
DISCUSSION
The purpose of this study was to evaluate whether a family history of schizophrenia or
bipolar disorder in first-degree relatives was associated with ASD. We analyzed three
samples to understand whether an association was specific to one sample or generalized
across samples.
The findings were clear. The presence of schizophrenia or bipolar disorder in first-degree
relatives was a consistent and significant risk factor for ASD in all three samples. Moreover,
a comparable register-based study from Denmark showed similar findings for the
association of parental schizophrenia-like psychosis with ASD (OR=4.8, 95% CI 2.4–9.5) 9.
We speculate that the higher sibling OR from Israel resulted from subjects with earlier onset
schizophrenia which has a higher sibling recurrence risks 39. The findings from these four
samples are depicted in Figure 1. These remarkably consistent findings have a number of
immediate implications.
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These findings have implications for etiological research. The statistical model we used to
calculate the risk associated with “exposure” to the presence of schizophrenia in parents or
siblings on the outcome of ASD was one of convenience. This model is likely incomplete.
We speculate that the true underlying etiological model contains an unmeasured confounder
and, moreover, does not explicitly model etiological heterogeneity (which is plausible and
generally assumed for these complex disorders). The confounder could be DNA sequence
variation shared between the ASD probands and their parents or siblings, a common
environmental risk factor to which all family members are exposed, or a gene-environment
interaction. Genetic effects may be more likely given substantial heritability estimates for
ASD 40, 41, schizophrenia 23, 42, and bipolar disorder 23, 43 along with evidence for relatively
lesser but significant environmental effects (empirical data suggest a significant role of
common environment in the etiology of both ASD and schizophrenia) 42, 44.
Our findings indicate that ASD, schizophrenia, and bipolar disorders share etiological risk
factors. We suggest that future research could usefully attempt to discern risk factors
common to these disorders. As one example, the Psychiatric Genomics Consortium is now
conducting an integrated and relatively well-powered meta-analysis of all available genome-
wide association data to evaluate whether there are associations common to more than one
of ASD, schizophrenia, and bipolar disorder 45.
Family history has historically served as an important validator for definitions of psychiatric
disorders. If ASD, schizophrenia, and bipolar disorder share etiological risk factors, it does
not necessarily follow that the disorders should be lumped into an aggregate classification.
However, it is tenable that these disorders are more similar phenotypically than current
appreciated, and it might prove interesting to re-evaluate the degrees of demarcation
between these three disorders. Indeed, our findings are consistent with genomic data
showing that the same rare copy number variants of strong effect are risk factors for both
disorders. It may be that the clinical definitions of ASD and schizophrenia are derived from
exemplars, individuals who have particularly distinctive and unequivocal symptoms.
Definitions derived from exemplars may not be applicable to many cases seen clinically
whose complex and mutable combinations of symptoms may not respect these boundaries.
For individuals with ASD, assessment of psychotic symptoms is challenging particularly
when language and intelligence are compromised, and some individuals with ASD cannot be
evaluated. Even if assessment of psychosis is possible, the decision of whether a particular
sensation, cognition, or behavior constitutes a hallucination, delusion, or thought disorder is
a matter of interpretation and judgment 46. Some individuals with schizophrenia have
developmental histories not inconsistent with ASD 47.
In the discussion, we focused on family history of schizophrenia as a risk factor for ASD, as
the associations were generally stronger for schizophrenia than bipolar disorder. However,
given increasing evidence for etiological overlap between schizophrenia and bipolar
disorders 16, 22, we note that the analyses also support a common etiology between bipolar
disorder and ASD. One potential limitation of Study 1 is that the outpatient data in the
Swedish NPR is relatively new (started in 2001), and not yet complete. These data can thus
not be used for prevalence estimates, but should be unbiased with regard to the analyses
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presented here (we believe it unlikely that the variation in reporting from different health
care providers would be correlated with family history of psychotic symptoms).
In conclusion, our findings suggest that ASD, schizophrenia, and bipolar disorder share
common etiological factors. This conclusion is supported by the results of the three studies
reported here along with a fourth from the literature.
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Figure 1. Effect sizes
Forest plot of effects of exposure of schizophrenia in first-degree relatives on ASD outcome
in probands. The three samples reported here are shown along with a similarly conducted
study from Denmark 9.
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Table 2
Relation between exposures (family history of schizophrenia or bipolar disorder) and ASD outcomes.
Schizophrenia Bipolar disorder
Study 1 (Sweden national outpatient + inpatient)
    Parent 2.9 (2.5–3.4) 1.9 (1.7–2.1)
    Sibling 2.6 (2.0–3.2) 2.5 (2.1–3.0)
Study 2 (Stockholm outpatient + inpatient)
    Parent 2.9 (2.0–4.1) 1.6 (1.1–2.1)
    Parents of ASD cases + MR 2.6 (1.6–4.3) 1.1 (0.7–2.0)
    Parents of ASD cases - MR 2.6 (1.6–4.2) 1.7 (1.2–2.5)
Study 2 (Stockholm outpatient only)
    Parent 2.4 (1.6–3.6) 1.5 (1.1–2.0)
    Parents of ASD cases + MR 2.7 (1.3–5.5) 1.1 (0.7–1.8)
    Parents of ASD cases - MR 2.0 (1.1–3.4) 1.7 (1.2–2.4)
Study 3 (Israeli conscripts)
    Sibling 12.1 (4.5–32.5) N/A
Values shown are OR (95% confidence intervals, CIs). MR=mental retardation. Boldface indicates cells with 95% CIs that exclude 1.0.
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